ReviewPharmacoEconomics2019

Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Sarah Davis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.